No other concurrent anticancer chemotherapy [clinicaltrials_resource:264950b2783d77d411d5fb0f39b81d68]
eligibility for clinicaltrials:NCT00070109 [clinicaltrials_resource:2be59c7deb57fbbf3509352ef6f891c2]eligibility for clinicaltrials:NCT00053963 [clinicaltrials_resource:4833360561cc59f20af43d108f7362df]eligibility for clinicaltrials:NCT00091182 [clinicaltrials_resource:53966d5cec667b0284fb7970e9402264]eligibility for clinicaltrials:NCT00112463 [clinicaltrials_resource:752ddc144ff65abfb6913b7a8fadc131]eligibility for clinicaltrials:NCT00085540 [clinicaltrials_resource:758688ea2976b637472c0ec68e514e3f]eligibility for clinicaltrials:NCT00025363 [clinicaltrials_resource:c39f000ac79ba5a8ee435862fa72d2cb]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
No other concurrent anticancer chemotherapy [clinicaltrials_resource:264950b2783d77d411d5fb0f39b81d68]
Bio2RDF identifier
264950b2783d77d411d5fb0f39b81d68
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:264950b2783d77d411d5fb0f39b81d68
identifier
clinicaltrials_resource:264950b2783d77d411d5fb0f39b81d68
title
No other concurrent anticancer chemotherapy
@en
type
label
No other concurrent anticancer ...... 950b2783d77d411d5fb0f39b81d68]
@en